Nanotechnology Orchestrated Viral Annihilation (NOVA) – DTRA
AI Overview
DTRA is seeking prototype nanotechnology-based countermeasures that can neutralize multiple viruses at once, instead of the traditional one-virus-one-countermeasure approach. The goal is faster, broad-spectrum protection for warfighters against known, emerging, or unknown viral threats.
This summary is AI-generated from the official solicitation.
Key Details
Official Description
The Defense Threat Reduction Agency (DTRA), R&D Chemical and Biological Technologies Directorate — Medical Division, in support of the Joint Science and Technology Office (JSTO) and in collaboration with CPE-CBRND, is seeking prototype nanotechnology-based medical countermeasures for viral threats to the warfighter in both pre- and post-exposure scenarios.
Today, countermeasures are typically developed one-to-one — a single countermeasure per virus, each tuned to a specific immune response...
Change History
Nanotechnology Orchestrated Viral Annihilation (NOVA) – DTRA
New opportunity: Nanotechnology Orchestrated Viral Annihilation (NOVA) – DTRA
Similar Opportunities
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial